Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Allison A. Venner
Navigating the risks and benefits of implementing a new laboratory information system
There are many good reasons to transition to a new laboratory information system (LIS), especially when doing so is partnered and aligned with implementing a new clinical information system (CIS). In making this shift, clinical labs move away from fragmented patient information and healthcare workflows and toward centralized access to health information and best practices for all who connect with the new system. But that does not mean the process comes without risks and obstacles.
Canadian Society of Clinical Chemists Harmonized Pediatric Lipid Reporting Recommendations for Clinical Laboratories
Abstract Detecting dyslipidemia early is important because atherosclerosis originates in childhood and early treatment can improve outcomes. In 2022, CCS/CPCA published a Clinical Practice Update to detect, evaluate, and manage pediatric dyslipidemia. However, guidance on its translation into clinical laboratories is lacking.
Evaluation of the ID NOW among symptomatic individuals during the Omicron wave
Abstract Introduction. Starting in December, 2020, the ID NOW was implemented throughout the province of Alberta, Canada (population 4.4 million) in various settings. Gap statement. ID NOW’s test performance with SARS-CoV-2 Omicron variant BA.1 is unknown. Aim. To assess the ID NOW performance among symptomatic individuals during the BA.1 Omicron wave and compare it to previous SARS-CoV-2 variant waves. Methodology.
Canadian Society of Clinical Chemists (CSCC) Harmonized Clinical Laboratory Lipid Reporting Recommendations based on 2021 Canadian Cardiovascular Society Lipid Guidelines
Abstract There is limited guidance on laboratory reporting and interpretation of lipids and lipoproteins used in cardiovascular risk stratification. This contributes to inconsistencies in lipid reporting across clinical laboratories. Recently, the Canadian Cardiovascular Society (CCS) published the 2021 CCS Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.
Point of care molecular and antigen detection tests for COVID-19: current status and future prospects
• None , , , et al. Then and NOW: a prospective population-level validation of the abbott ID NOW SARS-CoV-2 Device implemented in multiple settings for testing asymptomatic and symptomatic individuals . MedRxiv. ; . • This was a large validation comparing performance of the Abbott ID Now with laboratory RT PCR. The authors studied performance in a variety of patient populations/settings and looked at performance in both symptomatic and asymptomatic individuals , et al.. MedRxiv..
Search Results | Microbiology Society
1 - 1 of 1 for "Allison A. Venner" Publication Journal of Medical Microbiology (1) Keyword COVID-19 (1) ID NOW (1) POCT (1) SARS-CoV-2 (1) rapid diagnostics (1) symptomatic (1) Content type Access Type
Search Results | Microbiology Society
Introduction. The ID NOW is FDA approved for the detection of SARS-CoV-2 in symptomatic individuals within the first 7 days of symptom onset for COVID-19 if tested within 1 h of specimen collection. Gap statement. Clinical data on the performance of the ID NOW are limited with many studies varying in their study design and/or having small sample size. Aim. In this study we aimed to determine the clinical performance of the ID NOW compared to conventional RT-PCR testing. Methodology.
Search Results | Microbiology Society
1 - 2 of 2 for "Byron M. Berenger" Publication Journal of Medical Microbiology (2) Keyword ID NOW (2) COVID-19 (1) COVID-19 diagnostics (1) POCT (1) SARS-CoV-2 (1) rapid SARS-CoV-2 test (1) rapid diagnostics (1) symptomatic (1) Content type Access Type
A Snapshot of Lipid Reporting Practices in Canadian Clinical Laboratories: An Urgent Need for Harmonization
Abstract To effectively implement the Canadian Cardiovascular Society (CCS) Guidelines for dyslipidemia management into clinical laboratories, clear recommendations for lipid reporting are essential. In this study, the Canadian Society of Clinical Chemists (CSCC) Working Group on Reference Interval Harmonization (hRI) surveyed Canadian laboratories on adult lipid reporting practices to set a foundation for the development and implementation of harmonized lipid reporting across Canada.
Clinical Microbiology and Infection
Please select at least one article in order to proceed.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Allison A.
Contact Allison A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack